PragmaClin® was born from an unlikely but powerful partnership between Bronwyn Bridges, a young scientist and entrepreneur, and Gord Genge, a passionate advocate living with Parkinson’s Disease. When they first met, Bronwyn was conducting research on Parkinson’s, and Gord had just been diagnosed. Their shared frustration with outdated assessment methods—and their determination to change the status quo—sparked the creation of PragmaClin.

​

Bronwyn, now the CEO and a PhD candidate, used her scientific background and drive for impact to lead the development of PRIMS®, a digital assessment system designed to improve how clinicians monitor neurological conditions. With over $2 million in secured funding and numerous national awards under her belt, Bronwyn continues to push the boundaries of what’s possible in digital health.

​

Though Gord is no longer actively involved in day-to-day operations, his early vision and lived experience helped shape the foundation of PragmaClin’s mission: to empower patients and clinicians with better tools for better care.